Evidence mapPaperPMID 41226512Full record

ArticleInternational journal of molecular sciences2025

Cellular cAMP Content and Mitochondrial Profile Define Different Subtypes of Ovarian Cancer Cells.

Daniela De Benedictis, Aasia Bibi, Luigi Leonardo Palese, Antonella Cormio, Clara Musicco, Vera Loizzi, Gennaro Cormio, Ali Abdelhameed, Domenico De Rasmo, Anna Signorile

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniela De BenedictisDepartment of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, 70124 Bari, Italy.ORCID 0009-0008-9129-6578
Aasia BibiDepartment of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, 70124 Bari, Italy.ORCID 0000-0002-7005-2346
Luigi Leonardo PaleseDepartment of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, 70124 Bari, Italy.ORCID 0000-0002-3447-1535
Antonella CormioDepartment of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, 70124 Bari, Italy.ORCID 0000-0002-6029-1722
Clara MusiccoInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council of Italy (CNR), 70124 Bari, Italy.ORCID 0000-0003-4359-4403
Vera LoizziDepartment of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, 70124 Bari, Italy.ORCID 0000-0002-4006-6421
Gennaro CormioS.C. Ginecologia Oncologia Clinicizzata, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.ORCID 0000-0001-5745-372X
Ali AbdelhameedDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, 11451 Riyadh, Saudi Arabia.ORCID 0000-0002-5910-2832
Domenico De RasmoInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council of Italy (CNR), 70124 Bari, Italy.
Anna SignorileDepartment of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, 70124 Bari, Italy.

Funding

King Saud University RSPD2025R750Regolazione dei sistemi redox e bioenergetici cellulari in condizioni fisio-patologiche, University of Bari Aldo Moro not applicable
6 · The paper itself

Abstract

Ovarian cancer (OC) is an aggressive and lethal gynecologic cancer due to its asymptomatic nature resulting in a late diagnosis. OC encompasses distinct histological subtypes, with serous OC representing the most common and aggressive form. However, within the same histological OC subtype, additional heterogeneity has been found in terms of genetic mutations and metabolic profiles probably contributing to treatment response. In cancer, metabolic reprogramming strongly involves mitochondria. Mitochondrial function can be regulated by the cAMP pathway, and its deregulation has been reported in various cancers including OC. Here we analyzed two serous OC cell lines, OC316 and OV56, and eleven human OC tissues. OC316 cell lines showed elevated cAMP level with respect to OV56. The high cAMP levels were associated with activation of thecAMP/PKA/CREB/PGC-1α axis resulting in increased mitochondrial biogenesis, respiratory chain activity, modulation of mitochondrial dynamics and apoptosis resistance. Accordingly, principal component analysis (PCA) of the twenty-three biochemical parameters, in eleven human OC tissues, classified OC into two groups showing different cAMP levels associated with distinct mitochondrial profiles. This analysis highlights a cAMP-dependent stratification revealing two mitochondrial subpopulations within serous OC. These findings indicate that the molecular heterogeneity of OC poses a challenge for understanding disease mechanisms and developing effective targeted therapies.

Indexed as

Cyclic AMPMitochondriaOvarian NeoplasmsApoptosisCell Line, TumorFemaleHumansPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSignal TransductionCyclic AMPPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humancAMPmitochondriaovarian cancer

Identifiers

PMID41226512
PMCPMC12607473

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.